MedPath

BIVALIRUDIN

BIVALIRUDIN

Discontinued
DIN Number

02450402

Drug Class

Human

Market Date

N/A

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02450402
AIG Number0148342001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AE06 BIVALIRUDIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:12.04.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

BIVALIRUDINActive
Strength: 250 MG / VIAL
Monograph: BIVALIRUDIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.